141 related articles for article (PubMed ID: 12879108)
1. Intraurethral and topical agents.
Lewis RW
Drugs Today (Barc); 2000; 36(2-3):113-9. PubMed ID: 12879108
[TBL] [Abstract][Full Text] [Related]
2. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
Raina R; Pahlajani G; Agarwal A; Zippe CD
BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
[TBL] [Abstract][Full Text] [Related]
3. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury.
Bodner DR; Haas CA; Krueger B; Seftel AD
Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612
[TBL] [Abstract][Full Text] [Related]
4. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study.
Shabsigh R; Padma-Nathan H; Gittleman M; McMurray J; Kaufman J; Goldstein I
Urology; 2000 Jan; 55(1):109-13. PubMed ID: 10654905
[TBL] [Abstract][Full Text] [Related]
5. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
6. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Engel JD; McVary KT
Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
[TBL] [Abstract][Full Text] [Related]
7. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
Fulgham PF; Cochran JS; Denman JL; Feagins BA; Gross MB; Kadesky KT; Kadesky MC; Clark AR; Roehrborn CG
J Urol; 1998 Dec; 160(6 Pt 1):2041-6. PubMed ID: 9817319
[TBL] [Abstract][Full Text] [Related]
8. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
Nehra A; Blute ML; Barrett DM; Moreland RB
Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the therapeutic approach of transurethral alprostadil.
Ekman P; Sjögren L; Englund G; Persson BE
BJU Int; 2000 Jul; 86(1):68-74. PubMed ID: 10886086
[TBL] [Abstract][Full Text] [Related]
10. MUSE therapy: preliminary clinical observations.
Werthman P; Rajfer J
Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
[TBL] [Abstract][Full Text] [Related]
11. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
Porst H
Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415
[TBL] [Abstract][Full Text] [Related]
12. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.
Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N
N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933
[TBL] [Abstract][Full Text] [Related]
13. Intracavernosal versus intraurethral alprostadil: a prospective randomized study.
Shokeir AA; Alserafi MA; Mutabagani H
BJU Int; 1999 May; 83(7):812-5. PubMed ID: 10368203
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea.
Kim SC; Ahn TY; Choi HK; Choi NG; Chung TG; Chung WS; Hwang TK; Hyun JS; Jung GW; Kim CI; Kim JJ; Kim SW; Lee CH; Lee KS; Lee WH; Min KS; Moon KH; Paic JS; Park KS; Park NC; Park YK; Seo JK; Seo KK; Shin JS; Yoon YR; Lee WC
Int J Impot Res; 2000 Apr; 12(2):97-101. PubMed ID: 11052635
[TBL] [Abstract][Full Text] [Related]
15. [Transurethral alprostadil administration with MUSE ("Medicated Urethral System for Erection"). Current overview and personal experiences].
Porst H
Urologe A; 1998 Jul; 37(4):410-6. PubMed ID: 9738294
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection.
Guay AT; Perez JB; Velásquez E; Newton RA; Jacobson JP
Eur Urol; 2000 Dec; 38(6):671-6. PubMed ID: 11111182
[TBL] [Abstract][Full Text] [Related]
17. Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis.
Benevides MD; Carson CC
J Urol; 2000 Mar; 163(3):785-7. PubMed ID: 10687977
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group.
Williams G; Abbou CC; Amar ET; Desvaux P; Flam TA; Lycklama à Nijeholt GA; Lynch SF; Morgan RJ; Müller SC; Porst H; Pryor JP; Ryan P; Witzsch UK; Hall MM; Place VA; Spivack AP; Gesundheit N
Br J Urol; 1998 Jun; 81(6):889-94. PubMed ID: 9666777
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
[TBL] [Abstract][Full Text] [Related]
20. [Transurethral alprostadil (MUSE) in erectile dysfunction].
Comeri G; Gianneo E; Nespoli R
Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
